Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

VTEB vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, VTEB returned −0.4% to XBI's +41.2%, and VTEB charges 0.03% to XBI's 0.35%.

askIQ about this page

askIQ about VTEB and XBI

Net assets: $49.6bn on Sep 30, 2026 for Vanguard Tax-Exempt Bond ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
−0.4%
VTEB total return, 1 year
+41.2%
XBI total return, 1 year
0.03%
VTEB expense ratio
0.35%
XBI expense ratio

Pair scorecard

VTEB costs 0.32 points a year less; their one-year returns differ by 41.6 points; VTEB is 4.8 times larger.

VTEB vs XBI: Differences, Returns & Fees
MeasureVTEBXBI
Return
Total return, 1 year−0.4%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksS&P National AMT-Free Municipal Bond IndexBiotech
Cost and size
Expense ratio0.03%0.35%
Net assets, as of Sep 30, 2026$49.6bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
In the S&P 500, by weight13%
Top ten holdings, share of the fund18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, VTEB and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first VTEB XBI
Only in one fund ↓
Only in VTEB
Vanguard Municipal Low Duration Fund 0.69%
State of California 0.15%
State of California 0.14%
New York State Dormitory Authority 0.13%
State of Illinois 0.12%
Ohio State University 0.12%
City of New York NY 0.10%
State of Wisconsin 0.10%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

VTEB Vanguard Tax-Exempt Bond ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of Tax-Exempt Bond Biotech
Total return, 1 year −0.4% +41.2%
Expense ratio 0.03% 0.35%
Holdings 11155 165
Net assets, VTEB as of Sep 30, 2026 and XBI as of Oct 27, 2026 $49.6bn $10.3bn

VTEB and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
VTEB

VTEB tracks an index of Tax-Exempt Bond. Over the year to Oct 28, 2026 it returned −0.4% with distributions reinvested. The prospectus expense ratio is 0.03% a year.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are VTEB and XBI in the same category?
VTEB is a bond ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, VTEB or XBI?
In the year to Oct 28, 2026, with distributions reinvested, VTEB returned −0.4% and XBI +41.2%.
Which is cheaper, VTEB or XBI?
VTEB is cheaper, by 0.32 percentage points a year. That is about $32 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, VTEB against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/vteb-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.